{
  "ptid_time": "022_S_1394_2007-05-29",
  "img_path": "/data/qiuhui/data/adni/images/022_S_1394/2007-05-29/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 59,120 mm³, 53.5% above the reference mean. With a Z-score of 1.28 (90.0th percentile), this represents mild enlargement; hippocampal volume measures 7,398 mm³, 2.1% below the reference mean. With a Z-score of -0.21 (41.8th percentile), this represents normal volume ; whole brain volume measures 1,079,730 mm³, 0.0% above the reference mean. With a Z-score of 0.00 (50.2th percentile), this represents normal volume ; entorhinal cortex volume measures 2,971 mm³, 27.5% below the reference mean. With a Z-score of -1.87 (3.1th percentile), this represents moderate atrophy; fusiform gyrus volume measures 13,996 mm³, 25.7% below the reference mean. With a Z-score of -2.19 (1.4th percentile), this represents significant atrophy; middle temporal gyrus volume measures 20,570 mm³, 3.6% below the reference mean. With a Z-score of -0.32 (37.3th percentile), this represents normal volume . ",
  "text_data": "Age is 77.1 years. Gender is Male. Education: 18 years. Handedness: Right. Race: White. Medical history: Head, Eyes, Ears, Nose and Throat; Respiratory; Musculoskeletal; Gastrointestinal; Allergies or Drug Sensitivities. MMSE: 27.0. Logical Memory: 5.0. APOEε4 alleles: 1.0. Biomarker levels: Amyloid beta: 391.20 pg/mL (moderate reduced); Total tau: 245.00 pg/mL (normal ); Phosphorylated tau: 24.90 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant atrophy in the entorhinal cortex and fusiform gyrus, both key regions affected in Alzheimer's disease (AD), alongside mild ventricular enlargement. The MMSE score of 27 is within normal limits, but the presence of moderate Aβ reduction (likely amyloid positivity) and APOE4 carrier status increases AD risk. The preserved hippocampal volume and normal tau levels suggest early-stage changes.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely due to Alzheimer’s pathology)  \n**Confidence:** **Medium** (MMSE is normal, but structural and biomarker findings suggest early neurodegeneration; clinical correlation needed for functional decline confirmation).  \n\n*Note: Progression to dementia is likely if episodic memory decline or functional impairment emerges.*",
  "timestamp": "2025-07-26T02:11:02.427638"
}